Astrana Health (NASDAQ:ASTH) Reaches New 1-Year Low – Should You Sell?

Shares of Astrana Health, Inc. (NASDAQ:ASTH) reached a new 52-week low on Friday . The company traded as low as $34.04 and last traded at $34.11, with a volume of 324004 shares changing hands. The stock had previously closed at $35.09.

Analyst Ratings Changes

Several brokerages recently weighed in on ASTH. Robert W. Baird boosted their price target on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. BTIG Research boosted their target price on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. Macquarie raised shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. TD Cowen started coverage on Astrana Health in a research note on Monday, October 14th. They set a “buy” rating and a $66.00 price objective on the stock. Finally, KeyCorp assumed coverage on Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Astrana Health presently has an average rating of “Moderate Buy” and an average target price of $65.17.

Astrana Health Price Performance

The stock has a 50 day moving average of $47.22 and a 200-day moving average of $47.88. The stock has a market capitalization of $1.90 billion, a P/E ratio of 25.92, a price-to-earnings-growth ratio of 1.80 and a beta of 1.13. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting analysts’ consensus estimates of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $478.71 million for the quarter, compared to analysts’ expectations of $462.01 million. During the same period in the prior year, the business posted $0.47 earnings per share. On average, equities research analysts anticipate that Astrana Health, Inc. will post 1.16 earnings per share for the current fiscal year.

Institutional Trading of Astrana Health

A number of large investors have recently modified their holdings of the company. State Street Corp bought a new stake in Astrana Health during the 3rd quarter valued at $91,966,000. Geode Capital Management LLC purchased a new stake in Astrana Health in the third quarter worth about $58,995,000. FMR LLC bought a new position in Astrana Health during the 3rd quarter worth about $48,413,000. SteelPeak Wealth LLC purchased a new position in Astrana Health during the 3rd quarter valued at about $39,398,000. Finally, Loomis Sayles & Co. L P bought a new stake in shares of Astrana Health in the 3rd quarter valued at about $30,251,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.